Endothelial cell repopulation after stenting determines in-stent neointima formation: Effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification

European Heart Journal

Volumn 34, Issue 43, 2013, Pages 3378-3388

  Douglas, Gillian ^a,b   Van Kampen, Erik ^a,b   Hale, Ashley B ^a,b   McNeill, Eileen ^a,b   Patel, Jyoti ^a,b   Crabtree, Mark J ^a,b   Ali, Ziad ^a,b   Hoerr, Robert A ^c   Alp, Nicholas J ^a,b   Channon, Keith M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Nanocopoeia Inc   (United States)

Author keywords

Artery; Endothelium; Mouse; Re endothelialization; Restenosis; Stent

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DNA MODIFICATION; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; IN-STENT RESTENOSIS; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ARTERY; ENDOTHELIUM; MOUSE; RE-ENDOTHELIALIZATION; RESTENOSIS; STENT;

ANIMALS; ASPIRIN; ATHEROSCLEROSIS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; MALE; MICE; MICE, INBRED STRAINS; NEOINTIMA; PACLITAXEL; STENTS; TUBULIN MODULATORS;

EID: 84890535783     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs240     Document Type: Article

References (30)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
2. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy J-J, Park S-J, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-Analysis. Lancet 2007;370:937-948.
3. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Banuelos C, Fernández-Ortiz A, Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
4. Räber L, Wohlwend L, Wigger M, Togni M, Wandel S, Wenaweser P, Cook S, Moschovitis A, Vogel R, Kalesan B, Seiler C, Eberli F, Lüscher TF, Meier B, Jüni P, Windecker S. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents /clinical perspective. Circulation 2011;123:2819-2828.
5. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004;44:733-739.
6. Ali ZA, Alp NJ, Lupton H, Arnold N, Greaves DR, Hu Y, Gunn J, Channon KM. Increased in-stent stenosis in ApoE-knockout mice: A novel mouse model of angioplasty and stenting. ATVB 2007;27:833-840.
7. Mayr U, Zou Y, Zhang Z, Dietrich H, Hu Y, Xu Q. Accelerated arteriosclerosis of vein grafts in inducible NO synthase2/2 mice is related to decreased endothelial progenitor cell repair. Circulation Res 2006;98:412-420.
8. Bai X, Margariti A, Hu Y, Sato Y, Zeng L, Ivetic A, Habi O, Mason JC, Wang X, Xu Q. Protein kinase Cd deficiency accelerates neointimal lesions of mouse injured artery involving delayed reendothelialization and vasohibin-1 accumulation. Arterioscler Thromb Vasc Biol 2010;30:2467-2474.
9. Larsen K, Cheng C, Tempel D, Parker S, Yazdani S, den Dekker WK, Houtgraaf JH, de Jong R, Swager-Ten Hoor S, Ligtenberg E, Hanson SR, Rowland S, Kolodgie F, Serruys PW, Virmani R, Duckers HJ. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 2011;33:120-128.
10. Tanous D, Bräsen JH, Choy K, Wu BJ, Kathir K, Lau A, Celermajer DS, Stocker R. Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 2006;189:342-349.
11. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333-342.
12. van Beusekom HMM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VWM, Verdouw PD, van der Giessen WJ. Long-Term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109-1117.
13. Ali ZA, Bursill CA, Douglas G, McNeill E, Papaspyridonos M, Tatham AL, Bendall JK, Akhtar AM, Alp NJ, Greaves DR, Channon KM. CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis. Circulation 2008;118(Suppl):S71-S77.
14. Liao S-J, Lin L, Zeng J-S, Huang R-X, Channon KM, Chen AF. Endotheliumtargeted transgenic GTP-cyclohydrolase I overexpression inhibits neointima formation in mouse carotid artery. Clin Exp Pharmacol Physiol 2007;34:1260-1266.
15. Xie H-H, Zhou S, Chen D-D, Channon KM, Su D-F, Chen AF. GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension. Hypertension 2010;56: 1137-1144.
16. Alp NJ, Mussa S, Khoo J, Guzik TJ, Cai S, Jefferson A, Rockett KA, Channon KM. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 2003;112:725-735.
17. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003;93:76-86.
18. Schroder K, Kohnen A, Aicher A, Liehn EA, Buchse T, Stein S, Weber C, Dimmeler S, Brandes RP. NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res 2009;105:537-544.
19. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
20. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230.
21. Bendall JK, Rinze R, Adlam D, Tatham AL, de Bono J, Channon KM. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-Targeted Nox2 transgenic mice. Circ Res 2007;100:1016-1025.
22. Ray JL, Leach R, Herbert JM, Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 2001;23:185-188.
23. de Bono JP, Warrick N, Bendall JK, Channon KM, Alp NJ. Radiochemical HPLC detection of arginine metabolism: measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide 2007;16:1-9.
24. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
25. Hayashi S-i, Yamamoto A, You F, Yamashita K, Ikegame Y, Tawada M, Yoshimori T, Shimizu S, Nakashima S. The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol 2009;175:2226-2234.
26. Hagensen MK, Shim J, Falk E, Bentzon JF. Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy. Arterioscler Thromb Vasc Biol 2011;31:808-813.
27. den Dekker WK, Houtgraaf JH, Onuma Y, Benit E, de Winter RJ, Wijns W, Grisold M, Verheye S, Silber S, Teiger E, Rowland SM, Ligtenberg E, Hill J, Wiemer M, den Heijer P, Rensing BJ, Channon KM, Serruys PWJC, Duckers HJ. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (GenousTM Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 2011;219:245-252.
28. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004; 44:1373.
29. Cho H-J, Kim T-Y, Cho H-J, Park K-W, Zhang S-Y, Kim J-H, Kim S-H, Hahn J-Y, Kang H-J, Park Y-B, Kim H-S. The effect of stem cell mobilization by granulocytecolony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol 2006;48:366-374.
30. Sharif F, Hynes SO, Cooney R, Howard L, McMahon J, Daly K, Crowley J, Barry F, O'Brien T. Gene-eluting stents: Adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 2008;16:1674-1680.